---
title: "MARGOLIN YAEL — Ownership Dossier"
canonical: https://whiteintel.dev/entity/7ff0226b-4bd3-5fbb-9fb2-6fd536e86ba6
json: https://whiteintel.dev/api/public/dossier/7ff0226b-4bd3-5fbb-9fb2-6fd536e86ba6
identifier: sec:0001868637
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# MARGOLIN YAEL

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001868637`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/7ff0226b-4bd3-5fbb-9fb2-6fd536e86ba6  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/7ff0226b-4bd3-5fbb-9fb2-6fd536e86ba6  

## Ownership & control

### Holdings / subsidiaries

- **BIONDVAX PHARMACEUTICALS LTD.** (director) — https://whiteintel.dev/entity/1215b2d5-78a0-5b8e-ba67-3e618c7a43b2
- **POINT BIOPHARMA GLOBAL INC.** (director) — https://whiteintel.dev/entity/43e8e7b1-fb25-50ef-88ea-ea634f8c1919

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **MARGOLIN YAEL**. Human view: https://whiteintel.dev/entity/7ff0226b-4bd3-5fbb-9fb2-6fd536e86ba6 · Structured JSON: https://whiteintel.dev/api/public/dossier/7ff0226b-4bd3-5fbb-9fb2-6fd536e86ba6._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._